Effects of MDMA on attention to positive social cues and pleasantness of affective touch. http://researchonline.ljmu.ac.uk/id/eprint/10667/ Article LJMU has developed LJMU Research Online for users to access the research output of the University more effectively. AbstractThe psychostimulant drug ± 3,4-methylenedioxymethamphetamine (MDMA) reportedly produces distinctive feelings of empathy and closeness with others. MDMA increases social behavior in animal models and has shown promise in psychiatric disorders such as autism spectrum disorder (ASD) and post-traumatic stress disorder (PTSD). How it produces these prosocial effects is not known. This behavioral and psychophysiological study examined the effects of MDMA, compared to the prototypical stimulant methamphetamine (MA), on two measures of social behavior in healthy young adults: i) responses to socially relevant, "affective" touch, and ii) visual attention to emotional faces. Men and women (N=36) attended four sessions in which they received MDMA (0.75 or 1.5mg/kg), MA (20mg), or a placebo in randomized order under double-blind conditions. Responses to experienced and observed affective touch (i.e., being touched or watching others being touched) were assessed using facial electromyography (EMG), a proxy of affective state. Responses to emotional faces were assessed using electrooculography (EOG) in a measure of attentional bias. Subjective ratings were also included. We hypothesized that MDMA, but not MA, would enhance ratings of pleasantness and psychophysiological responses to affective touch and increase attentional bias toward positive facial expressions. Consistent with this, we found that MDMA, but not MA, selectively enhanced ratings of pleasantness of experienced affective touch. Neither drug altered ratings of pleasantness of observed touch. On the EOG measure of attentional bias, MDMA, but not MA, increased attention toward happy faces. These results provide new evidence that MDMA can enhance the experience of positive social interactions; in this case pleasantness of physical touch and attentional bias toward positive facial expressions. The findings are consistent with evidence that the prosocial effects are unique to MDMA relative to another stimulant. Understanding the

Time perception is a fundamental component of everyday life. Although time can be measured using standard units, the relationship between an individual’s experience of perceived time and a standard unit is highly sensitive to context. Stressful and threatening stimuli have been previously shown to produce time distortion effects, such that individuals perceive the stimuli as lasting for different amounts of time as compared to a standard unit. As a highly social species, humans are acutely sensitive to social stressors; however, time distortion effects have not been studied in the context of social stress. We collected psychophysiological (electrocardiogram and impedance cardiography) and time perception data before, during, and after a modified version of the Trier Social Stress Test for 42 participants. Based on prior theories and evidence from the time perception literature, we hypothesized that experiencing a stressful event would result in time distortion. This hypothesis was supported by the data, with individuals on average reproducing short and long duration negative and positive stimuli as lasting longer after experiencing social stress, t(41) = −3.55, p = .001, and t(41) = −4.12, p <.001 for negative stimuli, and t(41)5 −2.43, p = .02, and t(41) = −3.07, p = .004 for positive stimuli. However, changes in time perception were largely unrelated to psychophysiological reactivity to social stress. These findings are in line with some other studies of time distortion, and provide evidence for the interoceptive salience model of time perception. Implications for mechanisms of time distortion are discussed.

Parkinson’s disease (PD) is typically well recognized by its characteristic motor symptoms (e.g., bradykinesia, rigidity, and tremor). The cognitive symptoms of PD are increasingly being acknowledged by clinicians and researchers alike. However, PD also involves a host of emotional and communicative changes which can cause major disruptions to social functioning. These incude problems producing emotional facial expressions (i.e., facial masking) and emotional speech (i.e., dysarthria), as well as difficulties recognizing the verbal and nonverbal emotional cues of others. These social symptoms of PD can result in severe negative social consequences, including stigma, dehumanization, and loneliness, which might affect quality of life to an even greater extent than more well-recognized motor or cognitive symptoms. It is, therefore, imperative that researchers and clinicans become aware of these potential social symptoms and their negative effects, in order to properly investigate and manage the socioemotional aspects of PD. This narrative review provides an examination of the current research surrounding some of the most common social symptoms of PD and their related social consequences and argues that proactively and adequately addressing these issues might improve disease outcomes.

No abstract

Rationale Methamphetamine (MA) use is steadily increasing and thus constitutes a major public health concern. Women seem to be particularly vulnerable to developing MA use disorder, as they initiate use at a younger age and transition more quickly to problematic use. Initial drug responses may predict subsequent use, but little information exists on potential gender differences in the acute effects of MA prior to dependence. Objective We examined gender differences in the acute effects of MA on subjective mood and reward-related behavior in healthy, non-dependent humans. Methods Men ( n = 44) and women ( n = 29) completed 4 sessions in which they received placebo or MA under double-blind conditions twice each. During peak drug effect, participants completed the monetary incentive delay task to assess reaction times to cues signaling potential monetary losses or gains, in an effort to determine if MA would potentiate reward-motivated behavior. Cardiovascular and subjective drug effects were assessed throughout sessions. Results Overall, participants responded more quickly to cues predicting incentivized trials, particularly large-magnitude incentives, than to cues predicting no incentive. MA produced faster reaction times in women, but not in men. MA produced typical stimulant-like subjective and cardiovascular effects in all participants, but subjective ratings of vigor and (reduced) sedation were greater in women than in men. Conclusions Women appear to be more sensitive to the psychomotor-related behavioral and subjective effects of MA. These findings provide initial insight into gender differences in acute effects of MA that may contribute to gender differences in problematic MA use. Electronic supplementary material The online version of this article (10.1007/s00213-019-05276-2) contains supplementary material, which is available to authorized users.